BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Europe's oligonucleotide landscape is entering a pivotal growt
 h phase. With the €21M launch of Aerska and major collaborations such as 
 Novartis and SciNeuron\, Lundbeck and Contera\, and Secarna and Vect-Horu
 s\, European biopharma are rapidly advancing RNA-targeted approaches to a
 ddress previously undruggable CNS diseases.&nbsp\;\n\nIn response to this
  momentum\, the inaugural Oligonucleotides for CNS Summit Europe will uni
 te 60+ senior industry leaders for the first European forum dedicated exc
 lusively to CNS-focused Oligonucleotide therapeutics.&nbsp\;\n\nThe summi
 t delivers three days of highly technical\, data-driven discussions addre
 ssing the challenges unique to CNS development with insight into next-gen
 eration BBB delivery strategies beyond TfR1\, advanced in vivo and iPSC m
 odels\, novel chemistry and conjugation approaches\, and translational st
 rategies bridging preclinical data to clinical and regulatory success.&nb
 sp\;\n\nNow is the moment to connect\, collaborate\, and shape the next w
 ave of RNA-based CNS innovation as the field accelerates globally.\n\n&nb
 sp\;\n\nDate and Time: On Tuesday April 21\, 2026 at 8:00 am to Thursday 
 April 23\, 2026 at 4:00 pm\n\nVenue details: Novotel Amsterdam Schiphol A
 irport\, 12 Taurusavenue\, Hoofddorp\, Noord-Holland\, 2132 LS\, Netherla
 nds\n
DTEND:20260423T160000
DTSTAMP:20260512T213555Z
DTSTART:20260421T080000
LOCATION:Novotel Amsterdam Schiphol Airport\, 12 Taurusavenue\, Hoofddorp\
 , Noord-Holland\, 2132 LS\,
SEQUENCE:0
SUMMARY:Europe's oligonucleotide landscape is entering a pivotal growth ph
 ase. With the €21M launch of Aerska and major collaborations such as Nova
 rtis and...
UID:20921616-0d85-4db6-bebb-007fc7520077
END:VEVENT
END:VCALENDAR